EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 174 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $4,475,000 | +31.1% | 90,414 | +34.9% | 0.00% | 0.0% |
Q4 2021 | $3,413,000 | -8.3% | 67,017 | +0.5% | 0.00% | 0.0% |
Q3 2021 | $3,720,000 | +76.9% | 66,690 | +35.7% | 0.00% | +100.0% |
Q2 2021 | $2,103,000 | +26.6% | 49,145 | +23.5% | 0.00% | 0.0% |
Q1 2021 | $1,661,000 | -4.6% | 39,798 | +6.4% | 0.00% | 0.0% |
Q4 2020 | $1,742,000 | +63.3% | 37,396 | +48.9% | 0.00% | 0.0% |
Q3 2020 | $1,067,000 | -10.9% | 25,107 | +0.7% | 0.00% | 0.0% |
Q2 2020 | $1,197,000 | -0.7% | 24,942 | -4.8% | 0.00% | 0.0% |
Q1 2020 | $1,205,000 | -36.6% | 26,197 | -17.2% | 0.00% | 0.0% |
Q4 2019 | $1,900,000 | -7.0% | 31,623 | -12.4% | 0.00% | -50.0% |
Q3 2019 | $2,043,000 | -10.7% | 36,119 | -12.1% | 0.00% | 0.0% |
Q2 2019 | $2,288,000 | +33.2% | 41,094 | +20.8% | 0.00% | +100.0% |
Q1 2019 | $1,718,000 | +123.1% | 34,032 | +78.1% | 0.00% | 0.0% |
Q4 2018 | $770,000 | -21.8% | 19,107 | +34.5% | 0.00% | 0.0% |
Q3 2018 | $985,000 | +6.3% | 14,211 | +16.0% | 0.00% | 0.0% |
Q2 2018 | $927,000 | -6.1% | 12,246 | -34.6% | 0.00% | 0.0% |
Q1 2018 | $987,000 | -6.4% | 18,725 | -5.2% | 0.00% | 0.0% |
Q4 2017 | $1,055,000 | +7.0% | 19,743 | +19.4% | 0.00% | 0.0% |
Q3 2017 | $986,000 | +66.3% | 16,532 | +120.0% | 0.00% | 0.0% |
Q2 2017 | $593,000 | +86.5% | 7,515 | +95.9% | 0.00% | – |
Q1 2017 | $318,000 | -75.9% | 3,836 | -76.9% | 0.00% | -100.0% |
Q4 2016 | $1,320,000 | +366.4% | 16,635 | +311.5% | 0.00% | – |
Q3 2016 | $283,000 | +36.7% | 4,043 | +73.0% | 0.00% | – |
Q4 2015 | $207,000 | – | 2,337 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |